Video
Evidence-Based Oncology: Future of Incentive-Driven Pathway Adherence
Evidence-Based Oncology: Future of Incentive-Driven Pathway Adherence, developed in collaboration with Healthcare Research & Analytics (HRA), outlines what the real impact of clinical pathways are on the oncology practice and what the key drivers of clinical pathways use are for both payers and providers.
The American Journal of Managed Care
Evidence-Based Oncology: Future of Incentive-Driven Pathway Adherence, developed in collaboration with Healthcare Research & Analytics (HRA), outlines what the real impact of clinical pathways are on the oncology practice and what the key drivers of clinical pathways use are for both payers and providers. Hosted by Drew Colon, Associate Publisher of , and Kevin Kelly, Executive VP and General Manager of HRA, this 30 minute webinar looks at the changing paradigm of the definition of value in oncology through implementation of and adherence to incentive-driven clinical pathways.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
